期刊文献+

沙利度胺联合苯丁酸氮芥治疗老年非霍奇金淋巴瘤的临床观察 被引量:3

Clinical study on thalidomide combined with chlorambucil in the treatment of the elderly patients with non- Hodgkin lymphoma(NHL)
在线阅读 下载PDF
导出
摘要 目的:探讨沙利度胺联合苯丁酸氮芥治疗老年非霍奇金淋巴瘤的疗效和毒副反应。方法:38例老年NHL患者接受沙利度胺联合苯丁酸氮芥口服,每3个月接受影像学检查(CT/MRI),骨髓涂片及活检,评价客观疗效及毒副反应。结果:38例患者中,完全缓解(CR)7例(18.4%),部分缓解(PR)16例(42.1%),总有效率(CR+PR)为60.5%。主要不良反应为可耐受的Ⅰ-Ⅱ度骨髓抑制、嗜睡、皮疹和脱发。结论:沙利度胺联合苯丁酸氮芥治疗老年NHL安全有效。 Objective To evaluate the efficacy and toxicities of thalidomide combined with chlorambucil in the treatment of the elderly patients with NHL. Method 38 elderly patients with NHL received thalidomide combined with chlorambucil. The efficacy and toxicity after three months were evaluated by iconography( CT / MRI),marrow aspiration and biospy. Results 7 patients achieved complete remission( CR),while 16 cases obtaining partial response( PR),the overall response rate was 60. 5%. The main toxicities were tolerable Ⅰ - Ⅱ degree of bone marrow suppression,drowsiness,skin rash and alopecia. Conclusion Thalidomide combined with chlorambucil is effective and safe for the elderly patients with NHL.
出处 《吉林医学》 CAS 2016年第2期272-273,共2页 Jilin Medical Journal
基金 2014年度江门市卫生和计划生育局科研立项[项目编号:14A044]
关键词 非霍奇金淋巴瘤 沙利度胺 苯丁酸氮芥 Non-Hodgkin lymphoma Thalidomide Chlorambucil
  • 相关文献

参考文献5

二级参考文献28

  • 1高磊,周倩,钱卫珠,范晓强,郭亚军.抗CD20单克隆抗体联合CHOP化疗方案治疗人B细胞淋巴瘤的实验观察[J].中华肿瘤防治杂志,2008,15(24):1864-1867. 被引量:4
  • 2郭荣平,钟崇,石明,张昌卿,韦玮,张亚奇,李锦清.血管内皮生长因子和基质金属蛋白酶-2在肝细胞肝癌中的表达及临床意义[J].中华肿瘤杂志,2006,28(4):285-288. 被引量:27
  • 3韩亚光,李富华.沙利度胺对人肝癌细胞株体外生长的影响[J].山东医药,2007,47(16):30-31. 被引量:2
  • 4Rajkumar SV. Current status of thalidomide in the treatment of cancer. Oncology, 2001, 15:867-874.
  • 5Rajkumar SV, Gertz MA, Lacy MQ, et al. Thalidomide as initial therapy for early-stage myeloma. Leukemia, 2003, 17:775-779.
  • 6Hwu WJ, Krown SE, Panageas KS, et al. Temozolomide plus thalidomide in patients with advanced melanoma : results of a dosefinding trial. J Clin Oncol, 2002, 20:2610-2615.
  • 7Stephens TD, Bunde CJ, Fillmore BJ. Mechanism of action in thalidomide teratogenesis. Biochem Pharmacol, 2000, 59 : 1489-1499.
  • 8Sauter ER, Nesbit M, Watson JC, et al. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck. Clin Cancer Res, 1999, 5 : 775-778.
  • 9Wrobel T,Mazur G,Usnarska-Zubkiewicz L,et al.Vascular endothelial growth factor (VEGF) serum concentration in non-Hodgkin's lymphoma patients.Pol Arch Med Wewn,2004,112:919-923.
  • 10Pro B,Younes A,Albitar M.Thalidomide for patients with recurrent lymphoma.Cancer,2004,100:1186-1189.

共引文献14

同被引文献23

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部